lipolife and Anglia Ruskin working in close partnership
Where lipolife had already established a market-leading product, Professor Najlah’s guidance and his team’s scientific rigour have resulted in significant improvements in existing products and possibilities for new, more complex combination formulas.
The knowledge and expertise of the scientific team have resulted in an optimised research, development and production process for lipolife products.
The partnership with Anglia Ruskin University solidifies an ongoing commitment to excellence and a mission to advance the scope of liposomal encapsulation within nutraceuticals.
Creating new products to meet demands of unmet health needs
The future for us is wide open. And so are the health concerns of the population. We want to be the bridge between the rising and exclusive costs of wellness products and the declining picture of health across the UK. Our knowledge, expertise and drive can only be a positive step to evolve the application of liposomal supplements. For us it’s not about consumer vanity, but actually helping those who may need us the most.
What does this mean for Anglia Ruskin?
Being able test the market to see which formulations work and which don’t, has also meant that within days the academic team can report back in real time, how the market responds to the science. This partnership allows the science to live, breath and provide applicable feedback to further understand how liposomal technologies perform to make the lives of our customers healthier.
What does the future look like?
With the partnership firmly in place, we will be creating new products. We have already outlined key areas in the product pipeline where we will develop our understanding of how formulating products using liposomal technology can improve all areas of the body.
Bringing on these capabilities has proved instrumental in being able to advance not only product line, but further the understanding of what we can do with liposomal technology. Establishing trust in the nutraceutical market is our greatest priority, but we have an eye on the future and will be seeking out new ways in which to use the technology to overcome unmet health needs.